While millions of Brits have credited weight loss medications like Mounjaro for allowing them to transform their health by losing weight, many now feel they will be unable to continue with treatment as the price will become unattainable
Popular injectable treatments are commonly used to treat diabetes, obesity, and other metabolic complications, including weight loss
- -
The White House says that "for too many Americans, these critical treatments are too expensive and therefore out of reach," and, "without insurance coverage, these drugs can cost someone as much as $1,000 a month." GLP-1 (glucagon-like peptide) receptor agonists are commonly prescribed to patients with type 2 diabetes (to stabilize blood glucose levels) or obesity (to assist with weight loss)
This new method could help people who use different medications and people who need healthcare
In addition, mouse studies have shown that butyrate contributes to maintain the colonic environment anaerobic through the activation of the peroxisome proliferator-activated receptor-gamma in colonocytes, which results in the induction of -oxidation (57)